For better or worse: A niche for Notch in parietal epithelial cell activation

Kidney International

Volumn 83, Issue 6, 2013, Pages 988-990

  Sweetwyne, Mariya T ^a   Susztak, Katalin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR;

CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FOCAL GLOMERULOSCLEROSIS; HUMAN; KIDNEY CELL; NONHUMAN; PARIETAL EPITHELIAL CELL; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84882253984     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.66     Document Type: Note

References (14)

1. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007; 71: 1205-1214.
2. Kriz W. Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 2002; 57: 189-195.
3. Kato H, Gruenwald A, Suh JH et al. Wnt/betacatenin pathway in podocytes integrates cell adhesion, differentiation, and survival. J Biol Chem 2011; 286: 26003-26015.
4. Niranjan T, Bielesz B, Gruenwald A et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008; 14: 290-298.
5. Sugimoto H, Mundel TM, Sund M et al. Bonemarrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci USA 2006; 103: 7321-7326.
6. Ronconi E, Sagrinati C, Angelotti ML et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 2009; 20: 322-332.
7. Fatima H, Moeller MJ, Smeets B et al. Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. Clin J Am Soc Nephrol 2012; 7: 1852-1858.
8. Dijkman H, Smeets B, van der Laak J et al. The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis. Kidney Int 2005; 68: 1562-1572.
9. Benigni A, Morigi M, Rizzo P et al. Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture. Am J Pathol 2011; 179: 628-638.
10. Smeets B, Kuppe C, Sicking EM et al. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 2011; 22: 1262-1274.
11. Ueno T, Kobayashi N, Nakayama M et al. Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promote collapsing focal segmental glomerulosclerosis with progressive podocyte loss. Kidney Int 2013; 83: 1065-1075.
12. Matsusaka T, Xin J, Niwa S et al. Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol 2005; 16: 1013-1023.
13. Talbot LJ, Bhattacharya SD, Kuo PC. Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int J Biochem Mol Biol 2012; 3: 117-136.
14. Cheng HT, Kim M, Valerius MT et al. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 2007; 134: 801-811.